Literature DB >> 23458638

The management of hepatobiliary cystadenomas: lessons learned.

Guillaume Martel1, Jamal Alsharif, Jean-Michel Aubin, Celia Marginean, Richard Mimeault, Robert J Fairfull-Smith, Waleed M Mohammad, Fady K Balaa.   

Abstract

BACKGROUND: Mucinous cystic neoplasms of the liver (hepatobiliary cystadenomas) are rare neoplastic lesions. Such cysts are often incorrectly diagnosed and managed, and carry a risk of malignancy. The objective of this study was to review the surgical experience with these lesions over 15 years.
METHODS: A retrospective chart review identified consecutive patients undergoing surgery for liver cystadenomas from 1997-2011. Clinical data were collected and summarized.
RESULTS: Thirteen patients (mean age 51 years, 12/13 females) with cysts 4.6-18.1 cm were identified. Most cysts were located in the left lobe/centrally (11/12) and had septations (8/13). Mural nodularity was infrequent (3/13). Nine patients had liver resection/enucleation, whereas four had unroofing. Frozen section analysis had a high false-negative rate (4/6). All patients had cystadenomas, of which two had foci of invasive carcinoma (cystadenocarcinoma) within mural nodules. There was no 90-day mortality. All but one patient (myocardial infarction) were alive at a median follow-up of 23.1 months. No patient with unroofing has developed malignancy to date.
CONCLUSIONS: Non-invasive hepatobiliary cystadenomas present as large central/left-sided cysts in young or middle-aged women. Associated malignancy was relatively uncommon and found within mural nodules. Intra-operative frozen section analysis was ineffective at ruling out cystadenomas. Complete excision is recommended, but close follow-up might be considered in patients with a prohibitive technical or medical risk, in the absence of nodularity on high-quality imaging.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23458638      PMCID: PMC3731583          DOI: 10.1111/hpb.12026

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  19 in total

1.  Intrahepatic biliary cystadenoma and cystadenocarcinoma: an experience of 30 cases.

Authors:  Chu Wang; Ruoyu Miao; Huilin Liu; Xiaojing Du; Liguo Liu; Xin Lu; Haitao Zhao
Journal:  Dig Liver Dis       Date:  2011-12-09       Impact factor: 4.088

2.  Case report: malignant transformation of biliary cystadenoma with mesenchymal stroma: documentation by CT.

Authors:  Y Matsuoka; K Hayashi; M Yano
Journal:  Clin Radiol       Date:  1997-04       Impact factor: 2.350

3.  Cystic disease of the liver.

Authors:  P M Sanfelippo; O H Beahrs; L H Weiland
Journal:  Ann Surg       Date:  1974-06       Impact factor: 12.969

4.  Cystadenoma and cystadenocarcinoma of the liver: a single center experience.

Authors:  David P Vogt; J Michael Henderson; Elaine Chmielewski
Journal:  J Am Coll Surg       Date:  2005-05       Impact factor: 6.113

5.  Effective treatment of biliary cystadenoma.

Authors:  K Tyson Thomas; Derek Welch; Andrew Trueblood; Paulgun Sulur; Paul Wise; D Lee Gorden; Ravi S Chari; J Kelly Wright; Kay Washington; C Wright Pinson
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma.

Authors:  P C Buetow; J L Buck; L Pantongrag-Brown; P R Ros; K Devaney; Z D Goodman; D F Cruess
Journal:  Radiology       Date:  1995-09       Impact factor: 11.105

7.  Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis.

Authors:  C Subramony; G A Herrera; E A Turbat-Herrera
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

8.  The prevalence of simple renal and hepatic cysts detected by spiral computed tomography.

Authors:  Z I Carrim; J T Murchison
Journal:  Clin Radiol       Date:  2003-08       Impact factor: 2.350

9.  Biliary cystadenocarcinoma: Case report of hepatic malignancy originating in benign cystadenoma.

Authors:  G L Woods
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

10.  Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.

Authors:  K Devaney; Z D Goodman; K G Ishak
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

View more
  6 in total

1.  Preoperative differential diagnosis between intrahepatic biliary cystadenoma and cystadenocarcinoma: a single-center experience.

Authors:  Fu-Bo Zhang; Ai-Min Zhang; Zhi-Bin Zhang; Xin Huang; Xi-Tao Wang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Complete resection for a giant recurrent biliary cystadenoma: A surgical case report and review of literature.

Authors:  Hoang Nguyen; Ngoc Cuong Nguyen; Thi Tra My Thieu; Tuan Hiep Luong; Ngoc Minh Tran; Dang Hung Nguyen; An Khang Nguyen
Journal:  Ann Med Surg (Lond)       Date:  2022-05-18

Review 3.  Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma.

Authors:  Kevin C Soares; Dean J Arnaoutakis; Ihab Kamel; Robert Anders; Reid B Adams; Todd W Bauer; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-14       Impact factor: 6.113

4.  Clinicopathological characteristics and prognostic factors of intrahepatic biliary cystadenocarcinoma.

Authors:  Ming-Yue Xu; Xian-Jie Shi; Tao Wan; Yu-Rong Liang; Hong-Guang Wang; Wen-Zhi Zhang; Lei He; Ming-Yi Chen; Shao-Cheng Lyu; Wen-Wen Zhang; Hui-Xing Li
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

5.  A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study.

Authors:  Hongzhen Wu; Zihua Wang; Yingying Liang; Caihong Tan; Xinhua Wei; Wanli Zhang; Ruimeng Yang; Lei Mo; Xinqing Jiang
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

6.  Primary chondrosarcoma of the liver: A case report.

Authors:  Zhuo-Yan Liu; Xue-Mei Jin; Guang-Hai Yan; Guang-Yu Jin
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.